(ALT) - Analyzing Altimmune's Short Interest
Portfolio Pulse from Benzinga Insights
Altimmune (NYSE:ALT) has seen a 15.44% increase in short interest since its last report, with 11.55 million shares sold short, representing 21.68% of its float. This places Altimmune's short interest significantly above its peer group average of 6.76%. While an increase in short interest can indicate bearish market sentiment, it can also be bullish under certain conditions.
March 22, 2024 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Altimmune's significant rise in short interest could indicate bearish sentiment but also potential for a bullish rebound.
The increase in short interest for Altimmune suggests that the market may have a bearish outlook on the stock. However, high short interest can also lead to a short squeeze if the stock's price starts to rise, potentially causing rapid price increases. The impact is neutral in the short term as it could swing either way based on market reactions and further developments.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100